ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028

Lifesciences | Pharmaceuticals

ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028

Market by Product, Application, End-user, and Country | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The Asia-Pacific pharmaceutical continuous manufacturing market is probable to exhibit growth at 11.11% of CAGR during the considered phase 2021-2028.


Report scope can be customized per your requirements. Request For Customization

The countries reviewed in this market include:

•        India

•        China

•        Japan

•        Australia & New Zealand

•        South Korea

•        ASEAN countries

•        Rest of APAC

In India, the pharmaceutical industry has grown significantly over the years, holding an important position in the global market. Moreover, the presence of professional scientists and engineers is likely to boost the industry across the country. According to the Indian Pharmaceutical Industry Report 2020, India is among the largest generic drug provider worldwide. However, it is estimated that the country’s pharma activities are required to shift from batch to continuous manufacturing to remain relevant in the competitive export situation. This has resulted in the pharmaceutical sector gearing up for the adoption of continuous manufacturing, which is further predicted to boost the pharmaceutical continuous manufacturing market over the considered period.

On the other hand, the surging aging population has resulted in a rise in the Japanese government’s healthcare expenditure. Moreover, the population over the age of 65 is likely to grow in the near future. Here, the government has implemented cost-effective measures, including promoting generic medicines and biennial drug cost adjustments. Several pharmaceutical companies are collaborating to cater to the high demand for generic drugs, further opting for continuous manufacturing. Therefore, these factors are estimated to drive the progress of the pharmaceutical continuous manufacturing market across Japan.

Hosokawa Micron Corporation is engaged in offering process solutions in powder & particle processing technology, blown film technology, and more. The company has its test centers for powder and particle processing technology, along with confectionery technology. Its product portfolio includes Modulomix, which is a continuous modular paddle mixer designed primarily for the pharmaceutical industry. It has its research facilities, engineering, and manufacturing services across the Asia-Pacific region, with its headquarter located in Osaka, Japan.  

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. PORTER’S FIVE FORCES MODEL

2.1.1.   THREAT OF NEW ENTRANTS

2.1.2.   THREAT OF SUBSTITUTE PRODUCTS

2.1.3.   BARGAINING POWER OF BUYERS

2.1.4.   BARGAINING POWER OF SUPPLIERS

2.1.5.   COMPETITIVE RIVALRY

2.2. IMPACT OF COVID-19 ON PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET

2.3. LEGAL, POLICY, & REGULATORY FRAMEWORK

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY INSIGHTS

2.7. MARKET DRIVERS

2.7.1.   RISE IN INITIATIVES BY REGULATORY AUTHORITIES FOR THE ADOPTION OF CONTINUOUS MANUFACTURING

2.7.2.   SURGING ACCEPTANCE OF PHARMACEUTICAL CONTINUOUS MANUFACTURING SYSTEMS

2.7.3.   RISING HEALTHCARE EXPENDITURE

2.8. MARKET RESTRAINTS

2.8.1.   LACK OF DEMAND FOR PCM SYSTEMS IN UNDERDEVELOPED ECONOMIES

2.8.2.   RISING CUSTOMER EXPECTATIONS FOR BETTER MEDICINES

2.9. MARKET OPPORTUNITIES

2.9.1.   INCREASING OPPORTUNITIES IN THE UNTAPPED EMERGING ECONOMIES

2.9.2.   SURGE IN THE MANUFACTURING OF LARGE MOLECULES AND BIOLOGICS

3.    ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY PRODUCT

3.1. INTEGRATED CONTINUOUS SYSTEM

3.2. SEMI-CONTINUOUS SYSTEM

3.3. CONTROL & SOFTWARE

4.    ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY APPLICATION

4.1. FINAL DRUG PRODUCT MANUFACTURING

4.2. API MANUFACTURING

5.    ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET OUTLOOK - BY END-USER

5.1. PHARMACEUTICAL COMPANIES

5.2. CONTRACT MANUFACTURING ORGANIZATIONS

5.3. OTHER END-USERS

6.    PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET - ASIA-PACIFIC

6.1. COUNTRY ANALYSIS

6.1.1. CHINA

6.1.2. INDIA

6.1.3. JAPAN

6.1.4. AUSTRALIA & NEW ZEALAND

6.1.5. SOUTH KOREA

6.1.6. ASEAN COUNTRIES

6.1.7. REST OF ASIA-PACIFIC

7.    COMPANY PROFILE

7.1. HOSOKAWA MICRON CORPORATION

7.2. GEA GROUP AG

7.3. LB BOHLE MASCHINEN + VERFAHREN GMBH

7.4. THERMOFISHER SCIENTIFIC INC

7.5. SIEMENS HEALTHINEERS

7.6. ELI LILLY & COMPANY

7.7. PFIZER INC

7.8. GLATT GMBH

7.9. SYNTEGON (FORMERLY BOSCH PACKAGING TECHNOLOGY)

7.10. GEBRUDER LODIGE MASCHINENBAU GMBH

7.11. KORSCH AG

7.12. COPERION GMBH

7.13. MUNSON MACHINERY COMPANY

8.    RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1:       ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2:       ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)

TABLE 3:       ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 4:       ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 5:       ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY INTEGRATED CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)

FIGURE 3:     ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY SEMI-CONTINUOUS SYSTEM, 2021-2028 (IN $ MILLION)

FIGURE 4:     ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTROL & SOFTWARE, 2021-2028 (IN $ MILLION)

FIGURE 5:     ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY FINAL DRUG PRODUCT MANUFACTURING, 2021-2028 (IN $ MILLION)

FIGURE 6:     ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY API MANUFACTURING, 2021-2028 (IN $ MILLION)

FIGURE 7:     ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY PHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)

FIGURE 8:     ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY CONTRACT MANUFACTURING ORGANIZATIONS, 2021-2028 (IN $ MILLION)

FIGURE 9:     ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 10:  CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 11:  INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 12:  JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 13:  AUSTRALIA & NEW ZEALAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 14:  SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 15:  ASEAN COUNTRIES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

FIGURE 16:  REST OF ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;